Boxer Capital Management, LLC
Q2 2025 13F-HR/A Holdings
Net value change ($000)
-133,810
(-40.2%)
New positions
8
Sold out positions
16
Turnover %
113.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TNGX | 35,808 | 251.8% |
| KYMR | 9,958 | 112.0% |
| iTeos Therapeutics, Inc. | 8,225 | NEW |
| URGN | 7,878 | NEW |
| CBIO | 7,322 | NEW |
| QURE | 4,589 | 57.7% |
| PTGX | 3,316 | NEW |
| NKTR | 3,230 | NEW |
| REPL | 3,029 | 17.3% |
| CDTX | 2,679 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| NUVL | -31,914 | -100.0% |
| RNAM | -25,535 | -100.0% |
| ANAB | -24,167 | -100.0% |
| XENE | -20,130 | -100.0% |
| RVMD | -17,430 | -37.4% |
| APLS | -15,593 | -100.0% |
| CHIMERIX INC | -15,403 | -100.0% |
| ELVN | -13,212 | -100.0% |
| Merus N.V. | -10,264 | -34.8% |
| ORIC | -9,668 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|